Get the Stockscreener App
3.11
5.18%
-0.17
Xbiotech Inc stock is traded at $3.11, with a volume of 19,468.
It is down -5.18% in the last 24 hours and down -27.00% over the past month.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
See More
Previous Close:
$3.28
Open:
$3.28
24h Volume:
19,468
Relative Volume:
0.29
Market Cap:
$99.99M
Revenue:
$4.01M
Net Income/Loss:
$-35.01M
P/E Ratio:
-2.681
EPS:
-1.16
Net Cash Flow:
$-24.53M
1W Performance:
-10.12%
1M Performance:
-27.00%
6M Performance:
-49.68%
1Y Performance:
-43.14%
1-Day Range:
$3.10
$3.33
1-Week Range:
$3.10
$3.5381
52-Week Range:
$3.10
$9.96
Xbiotech Inc Stock (XBIT) Company Profile
Name
Xbiotech Inc
Sector
Industry
Phone
512-386-2900
Address
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
3.10 | 99.99M | 4.01M | -35.01M | -24.53M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.62 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.80 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
653.26 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
274.52 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.28 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-14-19 | Initiated | Piper Jaffray | Overweight |
| Apr-21-17 | Downgrade | Noble Financial | Buy → Hold |
| Jun-28-16 | Reiterated | Noble Financial | Buy |
Xbiotech Inc Stock (XBIT) Latest News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire
XBiotech stock hits 52-week low at $3.5 amid market challenges - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Shareholders to Connect - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Shareholders to Reach Out - Markets Insider
Barclays PLC Boosts Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Stockholders to Inquire about Securities Investigation - Markets Insider
XBIT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into XBiotech Inc. and Encourages Investors to Contact the Firm - Markets Insider
XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm - Kilgore News Herald
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Stockholders to Reach Out - Markets Insider
Jane Street Group LLC Acquires Shares of 11,141 XBiotech Inc. (NASDAQ:XBIT) - Defense World
Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws - GlobeNewswire Inc.
XBiotech Inc.'s (NASDAQ:XBIT) largest shareholders are individual investors with 49% ownership, insiders own 35% - Yahoo Finance
Geode Capital Management LLC Acquires 22,059 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
Barclays PLC Acquires 18,761 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Walmart Inc.WMT - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire
State Street Corp Grows Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech Inc. Appoints Dr. Tak W. Mak to its Board of Directors - Defense World
XBiotech Appoints Renowned Scientist to Board of Directors - TipRanks
Franklin Resources Inc. Trims Stock Holdings in JD.com, Inc. (NASDAQ:JD) - Defense World
XBiotech (NASDAQ:XBIT) Has Debt But No Earnings; Should You Worry? - Simply Wall St
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc.SANA - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kzKSPI - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesCRBU - PR Newswire
XBiotech halts all rheumatology research after missing Phase II endpoints - Yahoo Finance
Stock market news: YSX Tech. -28.67%, XBiotech -24.76% among biggest losers during mid day trading - Business Upturn
Another bump in the road for XBiotech and bermekimab - The Pharma Letter
Xbiotech Shares Hit 52-Week Low on Halted Rheumatology Program - MarketWatch
XBiotech Stock Hits 52-Week Low at $3.75 Amid Market Fluctuations - Investing.com
Stock market today: XBiotech -31.66%, Nvni Group -31.59% among biggest losers in early trading - Business Upturn
XBiotech trading resumes - Nasdaq
XBiotech Halts Rheumatology Clinical Program - MarketWatch
XBiotech Pauses Rheumatology program - GlobeNewswire
XBiotech Halts Rheumatology Program After Major Data Irregularities Found in Phase 2 Trial - StockTitan
Fmr LLC Has $224,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech Inc. (NASDAQ:XBIT) Stock Position Lifted by Charles Schwab Investment Management Inc. - Defense World
(XBIT) Proactive Strategies - Stock Traders Daily
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
12,157 Shares in XBiotech Inc. (NASDAQ:XBIT) Purchased by MetLife Investment Management LLC - Defense World
XBiotech (NASDAQ:XBIT) vs. Ironwood Pharmaceuticals (NASDAQ:IRWD) Critical Analysis - Defense World
(XBIT) Investment Analysis and Advice - Stock Traders Daily
Connor Clark & Lunn Investment Management Ltd. Has $585,000 Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Trend Tracker for (XBIT) - Stock Traders Daily
Empowered Funds LLC Cuts Stock Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat
Cancer Cachexia Market Demand, Segments, And Growth to 2033 Helsinn, Aphios, Eli Lilly, XBiotech - openPR
How To Trade (XBIT) - Stock Traders Daily
XBiotech: Q3 Earnings Snapshot - New Haven Register
Xbiotech Inc Stock (XBIT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):